Despite the several common phenotypic and biochemical outputs of hepatic TRIM21 overexpression and A1CF silencing, we noticed that the improvement in steatosis was more profound in Ad-Trim21 mice compared with GalNAc-siA1cf–treated mice. This evidence concerns the gene A1CF and steatosis.